THE FIRST STEP TO PERSONALIZE AUTOIMMUNE DISEASE TREATMENT
We aim to develop novel IVD tools based on our Immunobiogram platform for autoimmune diseases, and other immune-based conditions, including (but not only) rheumatoid arthritis and lupus nephritis.
Ultimately, we strive to become a versatile IVD company with a large portfolio in immune-based indications.